Fifth Third Bancorp
APGNW

Fifth Third Bancorp’s Apexigen, Inc. WarrantApexigen, Inc. Warrant APGNW Stock Holding History

Fifth Third Bancorp’s Portfolio APGNW Stock Details APGNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-750
Closed – – 2785
2022
Q3 		$0 Buy
+750
New +$185 ﹤0.01% 2785

Other funds holding APGNW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
SM
Skaana Management Brooklyn, New York $296M AUM 65.1% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Fifth Third Bancorp's APGNW Position: Q4 2022 in Review

Fifth Third Bancorp sold out of Apexigen, Inc. WarrantApexigen, Inc. Warrant (APGNW) in Q4 2022, closing a stake of 750 shares.

Fifth Third Bancorp first reported a position in APGNW in Q3 2022 and held it in 1 quarter. The position peaked at $0 in Q3 2022. 18 funds tracked by Wall St. Rank hold APGNW as of Q4 2022.

  • Fifth Third Bancorp reported no remaining Apexigen, Inc. WarrantApexigen, Inc. Warrant position as of Q4 2022 after selling out during the quarter.
  • Fifth Third Bancorp sold 750 Apexigen, Inc. WarrantApexigen, Inc. Warrant shares in Q4 2022.
  • Fifth Third Bancorp first reported a position in Apexigen, Inc. WarrantApexigen, Inc. Warrant in Q3 2022 and held it in 1 quarter.
  • Fifth Third Bancorp's Apexigen, Inc. WarrantApexigen, Inc. Warrant position peaked at $0 in Q3 2022.
  • 18 funds tracked by Wall St. Rank held Apexigen, Inc. WarrantApexigen, Inc. Warrant as of Q4 2022.

Based on Fifth Third Bancorp's 13F filing for Q4 2022, filed 25 Jan 2023.